Antimicrobial Susceptibility Testing Market Size, Trends and Forecast 2024-2032

According to FutureWise analysis, the market for Antimicrobial Susceptibility Testing is expected to grow with a CAGR of 5.70% over the forecast period 2023-2031, and reach a market value of US$ 5.62 Billion by 2031.

Antimicrobial susceptibility testing (AST) is a laboratory technique used to assess the efficacy of antibiotics and other antimicrobial agents against a particular microorganism. This testing is important because it provides critical information to guide the selection of appropriate antimicrobial therapy for bacterial, fungal, and viral infections. AST involves the exposure of the microorganism to various concentrations of antimicrobial agents in vitro and the subsequent determination of the minimum inhibitory concentration (MIC) required to inhibit or kill the organism. The MIC is the lowest amount of an antimicrobial agent that can inhibit the growth of the microorganism.

AST can be performed using different methods, including disk diffusion, broth microdilution, agar dilution, and gradient diffusion. The disk diffusion method involves placing paper disks impregnated with different antimicrobial agents onto a bacterial culture plate and measuring the size of the zone of inhibition around the disk. The broth microdilution method involves preparing serial dilutions of the antimicrobial substance in a liquid growth medium and then inoculating the dilutions with the microorganism of interest. Agar dilution involves preparing a series of agar plates, each containing a different concentration of the antimicrobial agent.

FutureWise Market Research has published a report that provides an insightful analysis of Antimicrobial Susceptibility Testing Market trends affecting overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Antimicrobial-Susceptibility-Testing/7885

Antimicrobial Susceptibility Testing Market Segmentation: